NCT01735279View on ClinicalTrials.gov

Studying the Effects of Administration of Polyunsaturated Fatty Acids (PUFAS) of Omega-3 Series in Nicotine Dependence

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2014

Conditions
Tobacco DependenceNicotine Dependence
Interventions
DRUG

Omega 3

Each fish oil capsule contained 210.99 mg of EPA and 129.84 mg of DHA.

DRUG

Placebo

mineral oil + food dye #2 (simulating the colour of essential fatty acids); 1000 mg of mineral oil per capsule

Trial Locations (1)

55

Unidade de Dependência de Drogas (UDED), São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT01735279 - Studying the Effects of Administration of Polyunsaturated Fatty Acids (PUFAS) of Omega-3 Series in Nicotine Dependence | Biotech Hunter | Biotech Hunter